These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4375328)

  • 41. [Effect of hemodialysis on plasma-renin activity in patients with terminal kidney insufficiency].
    Wiesen K; Küppers H; Schnurr E
    Med Welt; 1977 Jan; 28(3):101-2. PubMed ID: 840018
    [No Abstract]   [Full Text] [Related]  

  • 42. Pressor response to angiotensin and plasma renin activity in anephric patients.
    Keynan A; Levy M; Czaczkes JW; Ullmann TD
    Isr J Med Sci; 1971 Oct; 7(10):1136-9. PubMed ID: 4335247
    [No Abstract]   [Full Text] [Related]  

  • 43. Control of plasma aldosterone during chronic hemodialysis.
    Studer A; Záruba K; Grimm J; Kuhlmann U; Siegenthaler W; Vetter W
    Clin Nephrol; 1980 Apr; 13(4):172-6. PubMed ID: 6991183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the metabolism of aldosterone in chronic renal failure and anephric man.
    Williams GH; Bailey GL; Hampers CL; Lauler DP; Merrill JP; Underwood RH; Blair-West JR; Coghlan JP; Denton DA; Scoggins BA; Wright RD
    Kidney Int; 1973 Oct; 4(4):280-8. PubMed ID: 4356505
    [No Abstract]   [Full Text] [Related]  

  • 45. [Tensional regulation of chronic renal insufficiency patients treated by hemodialysis. Roles in constrictive action of angiotensin and renin activity].
    Zech P; Sassard J; Moskvtchenko JF; Pozet N; Traeger J
    J Urol Nephrol (Paris); 1968 Dec; 74(12):970-6. PubMed ID: 4305947
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.
    Olgaard K; Madsen S; Ladefoged J; Regeur L
    Eur J Clin Invest; 1977 Feb; 7(1):61-6. PubMed ID: 402278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure regulation during chronic renal failure due to polycystic renal disease.
    Shapiro AP; Leenen FH; Galla SJ; Redmond DP; Vagnucci AH; McDonald RH
    Acta Physiol Lat Am; 1974; 24(5):432-8. PubMed ID: 4377500
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of plasma aldosterone during hemodialysis.
    Krämer BK; Ulshöfer TM; Müller GA; Ress KM; Risler T
    Int J Artif Organs; 1990 Jan; 13(1):32-8. PubMed ID: 2394492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
    Sciarra F; Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Concolino G
    Horm Res; 1977; 8(3):129-38. PubMed ID: 903075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sensitivity of the vascular system to angiotensin II and 1-norepinephrine before and after hemodialysis].
    Augustin HJ; Siemensen HC
    Z Kreislaufforsch; 1972 Jan; 61(1):66-74. PubMed ID: 4337462
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hemodialysis and hypertension].
    Fukuchi S; Takeuchi T; Nakajima K; Tsuchida S; Sugawara H
    Nihon Rinsho; 1972 Dec; 30(12):2470-7. PubMed ID: 4347356
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma renin activity and plasma aldosterone level in patients with chronic renal failure on maintenance haemodialysis.
    Kuska J; Kokot F
    Acta Med Pol; 1976; 17(3):183-92. PubMed ID: 998330
    [No Abstract]   [Full Text] [Related]  

  • 55. Control of aldosterone responsiveness in terminal renal failure.
    Weidmann P; Maxwell MH; De Lima J; Hirsch D; Franklin SS
    Kidney Int; 1975 May; 7(5):351-7. PubMed ID: 166231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
    Ivić M; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
    [No Abstract]   [Full Text] [Related]  

  • 57. Hypertension and chronic renal failure.
    Brown JJ; Düsterdieck G; Fraser R; Lever AF; Robertson JI; Tree M; Weir RJ
    Br Med Bull; 1971 May; 27(2):128-35. PubMed ID: 4325609
    [No Abstract]   [Full Text] [Related]  

  • 58. Control of plasma aldosterone in supine anephric man.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Reck G; Sigenthaler W
    Clin Endocrinol (Oxf); 1974 Oct; 3(4):411-9. PubMed ID: 4372001
    [No Abstract]   [Full Text] [Related]  

  • 59. Changes in plasma aldosterone following the administration of various combinations of stimuli.
    Gaillard RC; Riondel A; Merkelbach U; Vallotton MB
    Acta Endocrinol (Copenh); 1979 Oct; 92(2):309-18. PubMed ID: 227211
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.